Haemopoietic stem cell transplants: The impact of haemorrhagic complications

Blood Reviews

Volumn 17, Issue SUPPL. 1, 2003, Pages

  Bacigalupo, Andrea ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Allogeneic; Graft versus host disease; Haemopoietic stem cell transplant; Haemorrhage; Recombinant factor VIIa

Indexed keywords

HLA ANTIGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ALLOGRAFT; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; GENETIC COMPATIBILITY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MORTALITY; PRIORITY JOURNAL;

EID: 0242299073     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(03)90001-4     Document Type: Conference Paper

References (13)

1. Dominletto A, Raiola AM, van Lint MT, et al. Factors influencing haematologic recovery after allogeneic haemopoietic stem cells transplant: graft versus host disease, donor type, cytomegalovirus infections and cell dose. Br J Haematol 2001; 112: 219-227.
2. Gratwohl A, Hermans J. Indications and donor source of hemopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Bone Marrow Transplantation. Clin Transplant 1995; 9: 355-363.
3. Gratwohl A, Passweg J, Baldomero H, Hermans J, Urbano-Ispizua A. Hematopoietic stem cell transplantation in Europe 1998. Hematol J 2000; 1: 333-350.
4. Gratwohl A, Brand R, Apperley J, et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 2002; 100: 3877-3886.
5. Ferrara JLM. Cellular and cytokine effectors of acute graft versus host disease. Int J Hematol 2002; 76(Suppl 1): 195-198.
6. Robinet E, Tiberghien P. The graft-versus-host disease: a cytokine dysregulation model? Hématologie 2000; 6: 66-74.
7. Flowers MED, Kansu E, Sullivan KM. Hematopoietic stem cell therapy. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 1999; 13: 1091-1107.
8. Darmstadt GL, Donnenberg AD, Vogelsang GB, Farmer ER, Horn TD. Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host-disease. J Invest Dermatol 1992; 99: 397-402.
9. Bacigalupo A, Frassoni F, van Lint MT. Bone marrow or peripheral blood as a source of stem cells for allogeneic transplantation. Haematologica 2002; 87(Suppl 8): 4-8.
10. Nevo S, Enger C, Swan V, et al. Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival. Transplantation 1999; 67: 681-689.
11. Pihusch R, Salat C, Schmidt E, et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 2002; 74: 1303-1309.
12. Mahmoud H, Fahmy O, Kamel A, Kamel M, El-Haddad A, El-Kadi D. Peripheral blood vs. bone marrow as a source for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 1999; 24: 355-358.
13. Nevo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT) - incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood 1998; 91: 1469-1477.